These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35434902)

  • 1. Microwave focal therapy of prostate cancer: a non-clinical study and exploratory clinical trial.
    Boku H; Kaneko M; Yamada Y; Morinaga Y; Konishi E; Uno A; Ito-Ihara T; Yamada A; Horiguchi G; Teramukai S; Fujihara A; Shiraishi T; Yamada T; Ueda T; Matsugasumi T; Ohashi M; Horiuchi D; Inoue Y; Ukimura O
    BJU Int; 2022 Dec; 130(6):776-785. PubMed ID: 35434902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
    Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
    Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial.
    Barry Delongchamps N; Schull A; Anract J; Abecassis JP; Zerbib M; Sibony M; Jilet L; Abdoul H; Goffin V; Peyromaure M
    PLoS One; 2021; 16(7):e0252040. PubMed ID: 34260598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective Phase I study.
    Nair SM; Hatiboglu G; Relle J; Hetou K; Hafron J; Harle C; Kassam Z; Staruch R; Burtnyk M; Bonekamp D; Schlemmer HP; Roethke MC; Mueller-Wolf M; Pahernik S; Chin JL
    BJU Int; 2021 May; 127(5):544-552. PubMed ID: 33037765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
    Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
    J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol.
    Yamada Y; Shiaishi T; Ueno A; Kaneko M; Inoue Y; Fujihara A; Hongo F; Ukimura O
    Contemp Clin Trials Commun; 2019 Dec; 16():100471. PubMed ID: 31701044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy.
    Al-Hakeem Y; Raz O; Gacs Z; Maclean F; Varol C
    ANZ J Surg; 2019 Dec; 89(12):1610-1614. PubMed ID: 31679182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
    Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
    Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
    Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
    J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer.
    Oderda M; Marquis A; Calleris G; D'Agate D; Faletti R; Gatti M; Marra G; Gontero P
    Eur Urol Open Sci; 2022 Dec; 46():3-7. PubMed ID: 36304751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer.
    Anttinen M; Mäkelä P; Suomi V; Kiviniemi A; Saunavaara J; Sainio T; Horte A; Eklund L; Taimen P; Sequeiros RB; Boström PJ
    Scand J Urol; 2019 Oct; 53(5):295-302. PubMed ID: 31556779
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel Automated Three-Dimensional Surgical Planning Tool and Magnetic Resonance Imaging/Ultrasound Fusion Technology to Perform Nanoparticle Ablation and Cryoablation of the Prostate for Focal Therapy.
    Jue JS; Coons S; Hautvast G; Thompson SF; Geraats J; Richstone L; Schwartz MJ; Rastinehad AR
    J Endourol; 2022 Mar; 36(3):369-372. PubMed ID: 34409850
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
    Valerio M; Dickinson L; Ali A; Ramachadran N; Donaldson I; Mccartan N; Freeman A; Ahmed HU; Emberton M
    J Urol; 2017 Mar; 197(3 Pt 1):647-654. PubMed ID: 27697580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.
    Zlotta AR; Djavan B; Matos C; Noel JC; Peny MO; Silverman DE; Marberger M; Schulman CC
    Br J Urol; 1998 Feb; 81(2):265-75. PubMed ID: 9488071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.